World Class Speakers




Pascal Touchon, Senior Vice President, Global Head, Cell & Gene, Novartis Oncology Pascal Touchon
Senior Vice President, Global Head, Cell & Gene
Novartis Oncology

Joseph Eid, Senior Vice President, Head of Global Medical Affairs, Bristol-Myers Squibb Pharmaceuticals Joseph Eid
Senior Vice President, Head of Global Medical Affairs
Bristol-Myers Squibb Pharmaceuticals

Emma Lees, SVP Research, Jounce Therapeutics Emma Lees
SVP Research
Jounce Therapeutics

Lothar Germeroth, SVP, Managing Director, Juno Therapeutics Lothar Germeroth
SVP, Managing Director
Juno Therapeutics

Niklas Engler, Head, Technical Development, Biologics, Roche Niklas Engler
Head, Technical Development, Biologics

Prentice Curry, Vice President, Quality and Compliance, Kite Pharma Prentice Curry
Vice President, Quality and Compliance
Kite Pharma

Anne Goubier, Vice President, Immunology, Tusk Therapeutics Anne Goubier
Vice President, Immunology
Tusk Therapeutics

Matthew Hewitt, Director, Tumour Immunology & Microenvironment, Bellicum Pharmaceuticals Matthew Hewitt
Director, Tumour Immunology & Microenvironment
Bellicum Pharmaceuticals

Frédéric Triebel, Chief Scientific Officer, Chief Medical Officer, Prima BioMed Frédéric Triebel
Chief Scientific Officer and Medical Officer
Immutep Ltd

Deborah Charych, Executive Director, Nektar Therapeutics Deborah Charych
Executive Director
Nektar Therapeutics


The World Immunotherapy Congress agenda will feature 300+ speakers across multiple streams and co-located events.

Speakers will come from the most successful, innovative and thought-provoking companies from around the world. They will be supported by leading suppliers from the mega tech companies to the latest start-ups who are shaking up the industry.




Eric Abellan, Product Manager & Product Owner, INFORS HT

Marc Abromovitz, Head, Industrial Hygiene, Novartis

Marc Abromovitz at World Immunotherapy Congress

Horst Ackermann, Head HSE / Security bei Novartis, Novartis Pharma AG

Horst Ackermann at World Immunotherapy Congress

Kate Adcock, Director of Research and Innovation, The Muscular Dystrophy U.K.

Tudor Arvinte, President and Chief Executive Officer, Therapeomic Inc

Scott Askin, Digital Solutions Director, Digital Development, Portfolio, Strategy & Innovation (PS&I), Novartis Pharma

Scott Askin at World Immunotherapy Congress

Martin Axon, Principal, Occupational Hygienist of Operations for Europe, Safebridge

Martin Axon at World Immunotherapy Congress

Dani Bach, Director, Healthcare Ventures, I.P. Group Plc

Dani Bach at World Immunotherapy Congress

Jonathan Back, Deputy Director, Project Team Lead, Drug Discovery, Glenmark Pharmaceuticals SA

Calise Bahou, PhD Student, University College London

Marco Bardelli, Post-Doctoral Fellow, Institute for Research in Biomedicine

Hanmant Barkate, Vice President Medical Services, Glenmark Pharmaceuticals SA

Aji Barot, Commercial Director, HealthUnlocked

Fabio Baschiera, Functional Head Of Clinical Development, Oncology And Hematology, Novartis

Kevin Bateman, Distinguished Scientist, Merck Sharp & Dohme

Dr Roy Baynes, SVP of Head Global Clinical Development, Chief Medical Officer, Merck Sharp and Dohme (MSD)

Karoline Bechtold Peters, Senior Strategy & Technology Leader - Pharmaceutical Development, Novartis

Karoline Bechtold Peters at World Immunotherapy Congress

Dr Alain Beck, Senior Director, Biologics CMC & Developability, Centre d'Immunologie Pierre Fabre

Lukas Becker, PhD Student, University of Zurich

Roger Beerli, CSO, NBE Therapeutics

Roger Beerli at World Immunotherapy Congress

Stephen Beers, Associate Professor, University Of Southampton

Gary Bembridge, Senior Director Scientific Affairs – Immunology, Business Development, Abzena

Mehdi Benchoufi, Assistant Professor Centre d’Epidémiologie Clinique, APHP, Universite Paris Descartes Sorbonne Paris Cite_

Kaustubh Berde, Vice President for International Business : Emerging Markets, Wockhardt Limited

Kaustubh Berde at World Immunotherapy Congress

Krzysztof Bielikowicz, Principal Scientist, Analytical Development, Glenmark Pharmaceuticals SA

Alain Bindels, Head of Innovation Facilitation, Roche

Marc Bisschops, Director SLS, Pall Biotech

Leigh-Anne Blair, FORMER Senior Director - Clinical Operations, Onconova Therapeutics Inc

Leigh-Anne Blair at World Immunotherapy Congress

Phil Bland-Ward, Chief Scientific Officer, Crescendo Biologics Ltd

Phil Bland-Ward at World Immunotherapy Congress

Dr Ezio Bonvini, CSO, Macrogenics

Nicola Bonzanni, Chief Scientific Officer, ENPICOM

Louis Boon, Chief Scientific Officer, Bioceros

Caroline Boulliat, Immunology, Oncology. Biosimilar Business Unit Head, Amgen Europe GmbH

Ingrid Bourges, Clinical Assessor, Federal Agency for Medicines and Health Products

Ingrid Bourges at World Immunotherapy Congress

Katherine Bowers, Associate Principal Scientist, Fujifilm Diosynth Biotechnologies

Frank Brennan, Head of Non-Clinical Toxicology and PK/PD (Immunology), UCB Pharma

Tim Briggs, Director of Clinical and Applied Sciences, Leeds Beckett University

Dr Ulrich Brinkmann, Scientific Director, Expert Scientist, Roche

Johannes Brozy, Senior Associate Scientist, BiTE Technology, Amgen Inc

Sebastian Bunk, Research Director, Immunology, Immatics Biotechnologies GmbH

Patrick Burke, Associate Director, Seattle Genetics Inc

Alessandro Butte, Lecturer, E.T.H. Zurich

Alessandro Butte at World Immunotherapy Congress

Stefano Butti, Head of Sales Group, F.P.S. Food and Pharma Systems Srl

Stefano Butti at World Immunotherapy Congress

Paul Carter, Senior Director and Staff Scientist, Antibody Engineering, Genentech

Sarah Carter, Executive Director, Head of Global Study Operations, Amgen

Kieran Casey, Business Development Manager, Services, BioIVT

Tim Cave, VP-Head Strategic Planning and Digital Practices, Global Medical Affairs, GSK

Tim Cave at World Immunotherapy Congress

Brian Champion, CSO, Psioxus Therapeutics Ltd

Andre Choo, Principal Scientist and Director, Antibody Discovery, Bioprocessing Technology Institute

Mimi Choon-Quinones, Former Vice-Director, Clinical Operations EEMEA, Roche

Partha Chowdhury, Senior Director and Head, Antibody Discovery, Sanofi Genzyme

Partha Chowdhury at World Immunotherapy Congress

Theo Christie, Business Development Manager, NIHR Clinical Research Network

Vijay Chudasama, Reader, UCL

Daniela Cipolletta, Investigator III, Novartis

Jeannick Cizeau, Director of Research, Eleven Biotherapeutics

Jerome Cluzeau, Senior Scientist, Lek Pharmaceutical

Jerome Cluzeau at World Immunotherapy Congress

Kevin Collier, Sr. Director, Product – RAVE RTSM, Medidata Solutions

Nathalie Corvaïa, Managing Director, Institut De Recherche Pierre Fabre

Anthony Costello, Vice President Of Mobile Health, Medidata Solution

Delphine Courmier, Health Economics Director, Biosimilars, Amgen Inc

Thomas Cragnolini, Senior Manager C&Q, Recombinant Facility, CSL Behring

Thomas Cragnolini at World Immunotherapy Congress

Francis Crawley, Executive Director, Good Clinical Practice Alliance (GCPA)

Michel Crevoisier, former Senior QA Expert QA ChemOps CH, Novartis Ag

Vladka Čurin Šerbec, Head, Blood Transfusion Centre of Slovenia

Prentice Curry, Vice President Quality and Operations, Kite Pharma Inc

Rony Dahan, Assistant Professor, Weizmann Institute of Science

Kiran Dallenbach, Investment Analyst, Redalpine Venture Partners

Igor D'Angelo, Senior Scientist and Functional Lead, Amgen Inc

Huw Davies, Director of Business Development, Abcam

David Marc Davies, Post-doctoral Research Scientist, King's College London

Lee Dawson, Senior Scientist, Molecular Pathology Group, BioIVT

Dr John Delaney, Executive Director, Amgen Biologics Discovery, Amgen

Madiha Derouazi, Chief Executive Officer, Amal Therapeutics

Richard Dicicco, Chairman, Harvest Moon Pharmaceuticals

Richard Dicicco at World Immunotherapy Congress

Dr Rakesh Dixit, Vice President R&D, Global Head, Biologics Safety Assessment, MedImmune Inc

Claire Dobson, Director, Antibody Discovery & Protein Engineering, MedImmune

Claire Dobson at World Immunotherapy Congress

Margaret Dolan, Associate Director Market Access EU Biosimilars, Biogen

Dr Helena Domingues, Examiner, Joint Cluster Biotechnology, Immunology Directorate, European Patent Office

Dr Helena Domingues at World Immunotherapy Congress

Feng Dong, Senior Scientist Iii, AbbVie

Wendel Doubleday, Senior Director of Chemical Development, Seattle Genetics Inc

Wendel Doubleday at World Immunotherapy Congress

Roman Drai, Director, Clinical Development, Geropharm

Prof Stefan Duebel, Director, Braunschweig University of Technology

Mike Dyson, Chief Technology Officer, IONTAS Ltd

Joseph Eid, SVP, Bristol Myers Squibb

Niklas Engler, Head of Technical Development Biologics for Europe, F. Hoffmann-La Roche AG

Niklas Engler at World Immunotherapy Congress

Christoph Esslinger, CSO, Memo Therapeutics

Bernardo Estupinan, VP, Business Development, KBI Biopharma Inc.

Stephan Ewert, Senior Investigator, Novartis Pharma AG

Erin Federman, VP, Head of Biologics, Boehringer Ingelheim

Erin Federman at World Immunotherapy Congress

Caroline Feys, Research & Development Operations Innovation (RDO-I) Leader, Jansen

Caroline Feys at World Immunotherapy Congress

Ryan Fiehler, Principal Scientist, F-star Biotechnology Ltd

Mariangela Figini, Staff Researcher, Fondazione I.R.C.C.S. Istituto Nazionale dei Tumori

Bruno Filippi, Senior Research Associate, Z.H.A.W.

Jonny Finlay, CEO, UltraHuman

Dennis Flierman, Dierctor of Epitope Mapping, Pepscan Presto

Kalveer Flora, Specialist Pharmacist Rheumatology & Biosimilars, London North West Healthcare Nhs Trust

Kalveer Flora at World Immunotherapy Congress

Mathias Flume, Head of Drug Department, Kassenarztliche Vereinigung Westfalen-Lippe

Michael Von Forstner, Co-chair, Pharmacovigilance Working Group, Medicines for Europe

Michael Von Forstner at World Immunotherapy Congress

Agnete Fredriksen, President and Chief Scientific Officer, Vaccibody AS

Charlotte French, Executive Director of Portfolio Relationship and Sourcing Management, Astellas Pharma

Per Ola Freskgard, Vice Director & Expert Scientist, Roche Innovation Center Basel

Aidan Fry, Editor, Generics Bulletin

Tim Fugmann, Head Of Precision Medicine, Philochem

Patrick Garidel, Head of Process, Purification and Pharma Development, Biopharma, Boehringer Ingelheim Pharma GmbH & Co. KG

Lothar Germeroth, Senior Vice President and Managing Director, Juno Therapeutics

Dr David Gilham, Vice President of Research and Development, Celyad

Dr David Gilham at World Immunotherapy Congress

Chris Gomez, Head of Health, Safety and Environmental, Hovione

Jorge González Borroto, Pharmacovigilance Officer/Senior Toxicologist, Ferrer Internacional, S.A.

Jorge González Borroto at World Immunotherapy Congress

Niels Grabe, Director, Tissue Imaging and Analysis Center, University of Heidelberg Medical Center

Niels Grabe at World Immunotherapy Congress

Dr Ulf Grawunder, Chief Executive Officer & Founder, NBE Therapeutics

Sung-Hye Grieco, Senior Engineer at Early Stage Cell Culture, PTD Department, Genetech

Sung-Hye Grieco at World Immunotherapy Congress

Uwe Gudat, Head of Safety, Biosimilars, Fresenius Kabi

Keno Gutierrez, Investment Director, Merck Ventures

Thomas Hach, Director Healthcare Systems, Senior Global Heath Advisor, Novartis

Eric Halioua, President and Chief Executive Officer, PDC*line pharma SA

Haleh Hamedifar, CEO/Pharmacist, CinnaGen

Haleh Hamedifar at World Immunotherapy Congress

Tina Harris, Director Data Management, Amgen Inc

Dr Steffen Hartmann, Global Head Integrated Biologics Profiling, Novartis

Mark Anthony Haverick, Senior Scientist, MSD

Ian Henshaw, Global Head of Biogen’s Biosimilars Unit, Biogen

Guy Hermans, CSO, Isogenica Ltd

Andreas Herrmann, Chief Executive Officer, Valerius Biopharma

Andreas Herrmann at World Immunotherapy Congress

Olivier Heudi, Senior Investigator I, Novartis Ag

Matthew Hewitt, Director, Tumour Immunology & Microenvironment, Bellicum Pharmaceuticals

Kevin Heyries, Co Founder, Business Development and Strategy Lead, AbCellera Biologics Inc

Stuart Hicks, Associated Director of Pipeline Research & Development, ImmunoGen Inc

Oliver Hill, VP, Molecular Biology, Protein Engineering, Apogenix Ag

Huiguo (Forrest) Hu, General Manager of International Business, 3SBio Inc

Thomas Huber, Senior Investigator, Novartis Institute for Biomedical Research

Michael Hust, Group Leader, Technical University of Braunschweig

Adama Ibrahim, Senior Clinical Operations Lead, Biogen

Simon Ittig, CEO and Co-founder, T3 Pharmaceuticals

Ruediger Jankowsky, Managing Director, Cinfa Biotech

Ruediger Jankowsky at World Immunotherapy Congress

William Jia, CSO, Virogin Biotech

Henk Johan Streefkerk, Medical Director, PIQUR Therapeutics

Henk Johan Streefkerk at World Immunotherapy Congress

Christelle Johnson, Senior Field Applications Scientist, Cancer Genomics And Immuno-Oncology, Personalis

Kevin Johnson, Partner, Medicxi

Colette Johnston, Senior Director, Early Discovery, Crescendo Biologics Ltd

Dr Karin Jooss, Chief Scientific Officer, Gritstone Oncology

Anna Joy, Site Manager, Early Development & Clinical Pharmacology Global Clinical Operations, Janssen

Anna Joy at World Immunotherapy Congress

Meelis Kadaja, Director of Business Development, Icosagen Cell Factory OÜ

Klaus Peter Kammerer, Global Head Of Vendor Management And Oversight, Knowledge Management And Quality Management, Boehringer Ingelheim

Hélène Kaplon, Post-doctoral Research Fellow, Servier France

Jan Pieter Kappelle, Senior Director Global Clinical Supplies, UCB Pharma

Ghassan Karam, Project Manager, W.H.O. I.C.T.R.P.

Dr Maria Karasarides, Executive Director, ImmunoOncology, Regeneron Pharmaceuticals

Dr Maria Karasarides at World Immunotherapy Congress

Marc-André Kasper, Research Scientist, F.M.P. Berlin

Andreas Katopodis, CEO, Anaveon

Robert Kelley, Principal Scientist, Genentech

Saad Kenderian, Assistant Professor of Medicine, Oncology, and Immunology Director, T Cell Engineering Program, Mayo Clinic

Saad Kenderian at World Immunotherapy Congress

Rupert Kenefeck, Group Leader, Immunocore Ltd

James Kent, Specialist Procurement Pharmacist London & East of England, NHS England

Houng Kim, head of the strategy and operations division, Celltrion Healthcare

Houng Kim at World Immunotherapy Congress

Krista Kinneer, Scientist Ii, MedImmune Inc

Takashi Kei Kishimoto, Chief Science Officer, Selecta Biosciences Inc

Roland Kontermann, Professor Of Biomedical Engineering, University of Stuttgart

Dr Jiri Kovarik, Research Investigator, N.I.B.R.

Suzette Kox, Senior Director International - Biosimilar Medicines Group Medicines for Europe, Medicines for Europe A.I.S.B.L.

Suzette Kox at World Immunotherapy Congress

Michael Kuhnen, Team Manager, Hosokawa Alpine

Michael Kuhnen at World Immunotherapy Congress

Martin Kuster, Head Corporate Health & Biosafety, Novartis

Anne Kvarnhammar, Senior Scientist, Alligator Bioscience

Kai Langel, Director, R&D Operations Innovation, Janssen Pharmaceutica

Kai Langel at World Immunotherapy Congress

Heinz Läubli, Attending Physician, Medical Oncology, University Hospital Basel

Andreas Hougaard Laustsen, Postdoctoral Fellow, Technical University of Denmark

Andy Lee, Senior Vice President and Head of Global Clinical Trial Operations, Merck

Disa Lee Choun, Head of Innovation, GCSO, UCB

Disa Lee Choun at World Immunotherapy Congress

Jeanette Leusen, Associate Professor, Laboratory, Translational Immunology, UMC Utrecht

Adam Levysohn, Head of Global Market Access Biogen Biosimilars Business Unit, Biogen

Zhaoyang Megan Li, Senior Director, Clinical Pharmacology, Shire

Chris Lloyd, Senior Scientist, Protein Engineering, Antibody Discovery and Protein Engineering, MedImmune U.K. Ltd

Ester Lovsin Barle, Corporate Toxicologist, Lonza

Juergen Lukas, Boehringer Ingelheim

Nicolas Mach, Chief Scientific Officer, MaxiVax

Steinar Madsen, Medical Director, Norwegian Medicines Agency, Norway

Reinhold Maeck, Head of Corporation EH&S Regulatory Intelligence, Boehringer Ingelheim

Reinhold Maeck at World Immunotherapy Congress

Johannes Maier, Principal Scientist, Schrödinger

Mark Mamula, Professor of Medicine Rheumatology, Yale University

Julia Manzetti, PostDoc, Head of production of TILs, University Hospital Basel

Julia Manzetti at World Immunotherapy Congress

Andrea Marschall, Postdoctoral Fellow, Brandeis University

Peter Marshall, Principal Technology Engineer, AstraZeneca

Armelle Martelet, R&D Scientist, Proteomics, Sanofi

Rita Martello, Head of Laboratory, Sanofi

Scott Martin, Chair of the Steering Committee, CSDR

Dr Ivan Mascanfroni, Senior Scientist, Immunology Biologics, AbbVie

Dr Ivan Mascanfroni at World Immunotherapy Congress

Justin Mason-Home, Director, HPAPI Services Limited

Krzysztof Masternak, Head of Biology, NovImmune Sa

Ted Mathias, Partner, Axinn

Ivana Matic, Global Operations Lead- Agreements, MSD

Salah Mawajdeh, Senior Vice President, Regulatory and Medical Affairs and Head MENA Business, Hikma Pharmaceuticals

Lamine Mbow, Senior Vice President & Head, Glenmark Pharmaceuticals SA

Tim McCarthy, Deputy Chief Pharmacist, Royal Marsden NHS Foundation Trust

Victor Lino Mendonça, VP Global Policy & Market Access Europe, Mylan

Victor Lino Mendonça at World Immunotherapy Congress

Dr Christoph Merten, Group Leader and Principal Investigator Genome Biology Unit, European Molecular Biology Laboratory

Derek Michael Mason, PhD Candidate, E.T.H. Zurich

Enkelejda Miho, Professor of Digital Life Science Sciences, University of Applied Sciences and Arts Northwestern Switzerland F.H.N.W.

Ali Mohamed, VP CMC, Immatics Inc

Vera Molkenthin, Chief Scientist, Abcheck s.r.o.

Dr M. Anthony Moody, Associate Professor of Paediatrics, Assistant Professor of Immunology, Duke University Medical Center

Melissa Jean Mottolo, Operational Intelligence Leader, Roche

Dafne Mueller, Group Leader, Institute of Cell Culture and Immunotherapy, University of Stuttgart

Hans Martin Mueller, Director, BioProcess Development, MSD

Stephen Nabarro, Head of Clinical Operations and Data Management, Centre for Drug Development, Cancer Research UK

Isabelle Naeije, Associate Director, Global Trial, Novartis

Prof Dr Dario Neri, Co-founder, Philogen; Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zurich

Mariann Neverovitch, Research Scientist, Bristol Myers Squibb

Sarfaraz Niazi, Chairman, Professor, Karyo Biologics/UIC

Cecil Nick, Vice President, PAREXEL

Johan Nilvebrant, Researcher, K.T.H. Royal Institute of Technology

Dr Ahuva Nissim, Professor, William Harvey Research Institute

Thomas Nittoli, Director, Regeneron Pharmaceuticals

Franz-Josef Obermair, CEO and Co-founder, Tepthera

Kate O'Brien, Former Senior Research Nurse, Independent Consultant

Jennifer O'Callaghan, Clinical Data Sharing Manager, Wellcome Trust

Jennifer O'Callaghan at World Immunotherapy Congress

Christian Ohmann, Chair of the Network Committee, E.C.R.I.N.

Benjamí Oller-Salvia, EMBO postdoctoral fellow, M.R.C. Laboratory of Molecular Biology

Dr Shane Olwill, Vice President of Development, Pieris Pharmaceuticals

Mareike Ostertag, Director Regulatory and Science Policy, Novartis Pharma AG

Eren Ozcagli, Academician, Istanbul University

Jeff Parry, Senior Scientist Manufacturability, AstraZeneca

David Passmore, Head of Commercial Operations, RubrYc Therapeutics

Francesco Patalano, Head Of Center Of Excellence Patient Reported Outcomes, Novartis

Nora Pencheva, Lead Scientist, Humax-AXL-ADC Program, Genmab

Nicole Piche-Nicholas, Principal Scientist, BioMedicine Design, Pfizer

Prof. Andreas Plueckthun, Professor of Biochemistry, Director, Department of Biochemistry, University of Zurich, Dept. of Biochemistry

Kerstin Pohl, Sr Support Specialist BioPharma EMEA, Sciex

Laurent Poirot, Head of Early Discovery, Cellectis

Ashley Polhemus, Innovation Specialist, Merck Sharp and Dohme

Abhinandan Raghavan, Data Scientist, Technology and Functional Leader, Informatics, Novartis Pharma AG

Ulrich Rant, Chief Executive Officer, Dynamic Biosensors

Ajan Reginald, CEO, Celixir

Dr Fabian Richter, Post-Doctoral Fellow, University of Stuttgart

Theo Rispens, Group Leader, Sanquin

Marc Robillard, Chief Executive Officer and Founder, Tagworks Pharmaceuticals

Matthew Robinson, Associate Director, Oncology Research, MedImmune Cambridge

Christoph Roesli, Senior Fellow, Global Drug Development, Novartis Pharma AG

Dr Stacie Ropka, Partner, Axinn

Michelle Rosenzwajg, MCU-PH, Pierre et Marie Curie University and Medical School

Karsten Roth, Director Clinical Operations, Cinfa Biotech

Nigel Saunders, SME Containment, GSK

Nigel Saunders at World Immunotherapy Congress

Martin Schiestl, Chief Science Officer, Sandoz (Novartis)

Thorsten Schmidt, Head of Department Biologics Research (Protein Therapeutics), R&D Germany, Sanofi

Jacky Schmitt, Head of Production, Celonic

Ulrich Scholz, Head of Scale Up and Processing, Bayer

Ulrich Scholz at World Immunotherapy Congress

Andreas Schreiner, Director of Validation, Manufacturing Science and Technology, Novartis Ag

Andreas Schreiner at World Immunotherapy Congress

Nabila Seddiki, Senior Lecturer, Paris-Est Créteil University

Peter Senter, Vice President of Chemistry, Seattle Genetics Inc

Armin Sepp, Scientific Leader and GSK Associate Fellow, GlaxSmithKline

Yossi Shapira, SME - Teva Global Engineering, Teva

Yossi Shapira at World Immunotherapy Congress

Dr Marjorie Shapiro, Supervisory Biologist Office of Biotechnology Products, CDER, FDA

Whitney Shatz, Senior Scientific Researcher, Genentech

Tim Shea, Director, Sterne Kessler Goldstein And Fox Plc

Jonathan Sheffield, Chief Executive Officer, NIHR Clinical Research Network

Darko Skegro, Senior Investigator, Novartis Institutes for Biomedical Research

Alan Smith, Executive Vice President, Technical Operations, Bellicum Pharmaceuticals

Anette Sommer, Principal Scientist, Bayer

Shantreddy Soogareddy, Associate Director - External Development R&D (Alliance and Project management), Dr. Reddy's Laboratories Limited

Philipp Spycher, PSI Founder Fellow, Paul Scherrer Institut

Anke Steinmetz, Senior Scientist, Integrated Drug Discovery/Structure, Design & Informatics, Sanofi

Frank Stenner, Professor of Medicine, Dep. of Oncology, Head of the Centre of Hemato-Oncology, University Hospital Basel

Don Stewart, President and Chief Executive Officer, PlantForm Corporation

Pawel Stocki, Senior Principal Scientist, Ossianix, Inc.

Cian Stutz, Team Leader, Antibody Engineering, Glenmark Pharmaceuticals SA

Mats Sundgren, Director, Health Informatics, AstraZeneca

Mats Sundgren at World Immunotherapy Congress

Satnam Surae, Chief Product Officer, Aigenpulse

Anna Tafuri, Medical Director, Translational Medicine Oncology, Bayer HealthCare

Ronen Tchelet, Vice President of Research and Business Development, Dyadic International Inc

Lioudmila Tchistiakova, Senior Director of Global Biotherapeutic Technologies, Pfizer

Jan-Willem Theunissen, Senior Director, Research, Iconic Therapeutics, Inc.

Thomas Thoma, Head Clinical Trials Supply, Teva Pharmaceuticals

Dean Thomas, Head of IP for Innovative Medicines and Biosimilars, Glenmark Pharmaceuticals SA

Greg Thurber, Assistant Professor of Chemical Engineering, University of Michigan

Pascal Touchon, Senior Vice President and Global Head Cell & Gene, Novartis

Dr Frédéric Triebel, Chief Scientific Officer and Medical Officer, Immutep Ltd

Gianluca Trifirò, Assistant Professor of Pharmacology, University of Messina

Gianluca Trifirò at World Immunotherapy Congress

Florian Turk, Head of Global Payor Marketing, Sales and Relations, Sandoz

Jonathan Underhill, Associate Director for Medicines Evidence, NICE

Jonathan Underhill at World Immunotherapy Congress

Thomas Valerius, Assistant Professor, Section for Stem Cell Transplantation and Immunotherapy, University Of Kiel

Maarten Van Baelen, Market Access Director, Medicines for Europe

Maarten Van Baelen at World Immunotherapy Congress

Peter Van Der Ark, Clinical Scientist, Janssen Pharmaceutical

Bernard Vanhove, Chief Operating Officer, Director of R&D and International Scientific Collaborations, O.S.E. Immunotherapeutics

Wouter Verdurmen, Assistant Professor, Radboud University Medical Center

Dr Alain Vertes, Managing Director, NxR Biotechnologies

Saskia Villinger, Scientist, Formulation & Process Development, Sanofi R&D

Meenu Wadhwa, Section Leader for Cyotkines and Growth Factors Section, NIBSC

Meenu Wadhwa at World Immunotherapy Congress

Sandesh Warudkar, Medical Advisor, Cadila Healthcare Ltd

Sandesh Warudkar at World Immunotherapy Congress

Dr Carl Webster, Principal Scientist, Antibody Discovery and Protein Engineering, MedImmune Cambridge

Kristina Westerlund, Research Scientist, K.T.H. Royal Institute of Technology

Lynsey Whilding, Research Associate, King's College London

Helen Wilkinson, Clinical Research Associate, Cancer Research UK

Mark Wright, Heal, Real World Clinical Studies, CPRD, MHRA

René Wuttke, Bioanalytical Principal Investigator, Global Bioanalytical Services, Celerion Inc.

Mingjie Xie, Chief Executive Officer, Rapid Novor Inc

Tianbo Xu, UCL

Vipul Yadav, Director of Product Development, Intract Pharma Limted

Yang Yang, Senior Scientist, Novartis

Alison Young, Staff Scientist, Fujifilm Diosynth Biotechnologies

Baolin Zhang, Senior Investigator and Review Team Leader, F.D.A. C.D.E.R.

Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter Plc



There are two parts to the Festival of Biologics: the five world-class international conferences covering Antibodies, Immunotherapy, BioSimilars, Clinical Trials, and High Potency APIs; and an exhibition featuring the most exciting technology and solutions for pharma and biotech. There is a registration fee to attend the conferences. To visit the exhibition is free.

Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October 

Sign Up for Event Updates